Rare Disease | Pfizer
Seeking to Improve Quality of Life for Children with Achondroplasia | Pfizer
In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia
Longitudinal Imaging of the Skull Base Synchondroses Demonstrate Prevention of a Premature Ossification
Postnatal Soluble FGFR3 Therapy Rescues Achondroplasia Symptoms and Restores Bone Growth in Mice
Development of Recifercept: Potential for use in Achondroplasia
